Lv3
340 积分 2023-02-28 加入
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
1天前
已完结
CML-395 Efficacy and Safety Results From ASCEMBL, a Phase III Study of Asciminib vs. Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): Week 96 Update
1个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
1个月前
已完结
BTK inhibitors: past, present, and future
1个月前
已完结
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)
5个月前
已完结
Evolving therapies for lower-risk myelodysplastic syndromes
6个月前
已完结
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
6个月前
已完结
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
6个月前
已完结
Imetelstat: First Approval
6个月前
已完结
Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes
6个月前
已完结
皖公网安备34019202002308
